Correlation Between Abcam PLC and Gain Therapeutics
Can any of the company-specific risk be diversified away by investing in both Abcam PLC and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcam PLC and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcam PLC and Gain Therapeutics, you can compare the effects of market volatilities on Abcam PLC and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcam PLC with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcam PLC and Gain Therapeutics.
Diversification Opportunities for Abcam PLC and Gain Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Abcam and Gain is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abcam PLC and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and Abcam PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcam PLC are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of Abcam PLC i.e., Abcam PLC and Gain Therapeutics go up and down completely randomly.
Pair Corralation between Abcam PLC and Gain Therapeutics
If you would invest 175.00 in Gain Therapeutics on December 1, 2024 and sell it today you would earn a total of 38.00 from holding Gain Therapeutics or generate 21.71% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Abcam PLC vs. Gain Therapeutics
Performance |
Timeline |
Abcam PLC |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Gain Therapeutics |
Abcam PLC and Gain Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Abcam PLC and Gain Therapeutics
The main advantage of trading using opposite Abcam PLC and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcam PLC position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.Abcam PLC vs. Anebulo Pharmaceuticals | Abcam PLC vs. Adagene | Abcam PLC vs. Acrivon Therapeutics, Common | Abcam PLC vs. AnaptysBio |
Gain Therapeutics vs. Beam Therapeutics | Gain Therapeutics vs. Editas Medicine | Gain Therapeutics vs. Caribou Biosciences | Gain Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |